Jiangsu Kanion Pharmaceutical Co.Ltd(600557) 3 released the annual performance report on March 3, which said that the operating revenue in 2021 was about 3.649 billion yuan, an increase of 20.34% year-on-year; The net profit attributable to the shareholders of the listed company was about 321 million yuan, a year-on-year increase of 21.92%; The basic earnings per share was 0.56 yuan, a year-on-year increase of 27.27%. The distribution scheme is: no bonus shares and no conversion to value-added shares.
Jiangsu Kanion Pharmaceutical Co.Ltd(600557) ‘s chairman is Xiao Wei, male, 63 years old, with a doctorate background; The general manager is Yang Yongchun, male, 49 years old, with a college education background.
\u3000\u3000
